237 related articles for article (PubMed ID: 26424674)
1. Co-trimoxazole prophylaxis in adults, including pregnant women, with HIV: a systematic review and meta-analysis.
Suthar AB; Vitoria MA; Nagata JM; Anglaret X; Mbori-Ngacha D; Sued O; Kaplan JE; Doherty MC
Lancet HIV; 2015 Apr; 2(4):e137-50. PubMed ID: 26424674
[TBL] [Abstract][Full Text] [Related]
2. Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.
Walker AS; Ford D; Gilks CF; Munderi P; Ssali F; Reid A; Katabira E; Grosskurth H; Mugyenyi P; Hakim J; Darbyshire JH; Gibb DM; Babiker AG
Lancet; 2010 Apr; 375(9722):1278-86. PubMed ID: 20347483
[TBL] [Abstract][Full Text] [Related]
3. Co-trimoxazole prophylaxis for children who are HIV-exposed and uninfected: a systematic review.
Wedderburn CJ; Evans C; Slogrove AL; Rehman AM; Gibb DM; Prendergast AJ; Penazzato M
J Int AIDS Soc; 2023 Jun; 26(6):e26079. PubMed ID: 37292018
[TBL] [Abstract][Full Text] [Related]
4. Effect of co-trimoxazole prophylaxis on morbidity and mortality of HIV-exposed, HIV-uninfected infants in South Africa: a randomised controlled, non-inferiority trial.
Daniels B; Coutsoudis A; Moodley-Govender E; Mulol H; Spooner E; Kiepiela P; Reddy S; Zako L; Ho NT; Kuhn L; Ramjee G
Lancet Glob Health; 2019 Dec; 7(12):e1717-e1727. PubMed ID: 31708152
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial.
Barsosio HC; Madanitsa M; Ondieki ED; Dodd J; Onyango ED; Otieno K; Wang D; Hill J; Mwapasa V; Phiri KS; Maleta K; Taegtmeyer M; Kariuki S; Schmiegelow C; Gutman JR; Ter Kuile FO
Lancet; 2024 Jan; 403(10424):365-378. PubMed ID: 38224710
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa.
Bwakura-Dangarembizi M; Kendall L; Bakeera-Kitaka S; Nahirya-Ntege P; Keishanyu R; Nathoo K; Spyer MJ; Kekitiinwa A; Lutaakome J; Mhute T; Kasirye P; Munderi P; Musiime V; Gibb DM; Walker AS; Prendergast AJ
N Engl J Med; 2014 Jan; 370(1):41-53. PubMed ID: 24382064
[TBL] [Abstract][Full Text] [Related]
7. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda.
Mermin J; Lule J; Ekwaru JP; Malamba S; Downing R; Ransom R; Kaharuza F; Culver D; Kizito F; Bunnell R; Kigozi A; Nakanjako D; Wafula W; Quick R
Lancet; 2004 Oct 16-22; 364(9443):1428-34. PubMed ID: 15488218
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial.
González R; Nhampossa T; Mombo-Ngoma G; Mischlinger J; Esen M; Tchouatieu AM; Mendes A; Figueroa-Romero A; Zoleko-Manego R; Lell B; Lagler H; Stoeger L; Dimessa LB; El Gaaloul M; Sanz S; Méndez S; Piqueras M; Sevene E; Ramharter M; Saúte F; Menendez C;
Lancet Infect Dis; 2024 May; 24(5):476-487. PubMed ID: 38224706
[TBL] [Abstract][Full Text] [Related]
9. Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trial.
Homsy J; Dorsey G; Arinaitwe E; Wanzira H; Kakuru A; Bigira V; Muhindo M; Kamya MR; Sandison TG; Tappero JW
Lancet Glob Health; 2014 Dec; 2(12):e727-36. PubMed ID: 25433628
[TBL] [Abstract][Full Text] [Related]
10. Revisiting Co-trimoxazole Prophylaxis for African Adults in the Era of Antiretroviral Therapy: A Randomized Controlled Clinical Trial.
Laurens MB; Mungwira RG; Nampota N; Nyirenda OM; Divala TH; Kanjala M; Mkandawire FA; Galileya LT; Nyangulu W; Mwinjiwa E; Downs M; Tillman A; Taylor TE; Mallewa J; Plowe CV; van Oosterhout JJ; Laufer MK
Clin Infect Dis; 2021 Sep; 73(6):1058-1065. PubMed ID: 33744963
[TBL] [Abstract][Full Text] [Related]
11. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
13. TSCQ study: a randomized, controlled, open-label trial of daily trimethoprim-sulfamethoxazole or weekly chloroquine among adults on antiretroviral therapy in Malawi: study protocol for a randomized controlled trial.
Laurens MB; Mungwira RG; Nyirenda OM; Divala TH; Kanjala M; Muwalo F; Mkandawire FA; Tsirizani L; Nyangulu W; Mwinjiwa E; Taylor TE; Mallewa J; Blackwelder WC; Plowe CV; Laufer MK; van Oosterhout JJ
Trials; 2016 Jul; 17(1):322. PubMed ID: 27431995
[TBL] [Abstract][Full Text] [Related]
14. Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial.
O'Connor J; Vjecha MJ; Phillips AN; Angus B; Cooper D; Grinsztejn B; Lopardo G; Das S; Wood R; Wilkin A; Klinker H; Kantipong P; Klingman KL; Jilich D; Herieka E; Denning E; Abubakar I; Gordin F; Lundgren JD;
Lancet HIV; 2017 Mar; 4(3):e105-e112. PubMed ID: 28063815
[TBL] [Abstract][Full Text] [Related]
15. When to start antiretroviral therapy in resource-limited settings.
Walensky RP; Wolf LL; Wood R; Fofana MO; Freedberg KA; Martinson NA; Paltiel AD; Anglaret X; Weinstein MC; Losina E;
Ann Intern Med; 2009 Aug; 151(3):157-66. PubMed ID: 19620143
[TBL] [Abstract][Full Text] [Related]
16. Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study.
Mermin J; Ekwaru JP; Liechty CA; Were W; Downing R; Ransom R; Weidle P; Lule J; Coutinho A; Solberg P
Lancet; 2006 Apr; 367(9518):1256-61. PubMed ID: 16631881
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of malaria and anaemia among HIV infected pregnant women receiving co-trimoxazole prophylaxis in Tanzania: a cross sectional study in Kinondoni Municipality.
Manyanga VP; Minzi O; Ngasala B
BMC Pharmacol Toxicol; 2014 Apr; 15():24. PubMed ID: 24761799
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa.
Hakim J; Musiime V; Szubert AJ; Mallewa J; Siika A; Agutu C; Walker S; Pett SL; Bwakura-Dangarembizi M; Lugemwa A; Kaunda S; Karoney M; Musoro G; Kabahenda S; Nathoo K; Maitland K; Griffiths A; Thomason MJ; Kityo C; Mugyenyi P; Prendergast AJ; Walker AS; Gibb DM;
N Engl J Med; 2017 Jul; 377(3):233-245. PubMed ID: 28723333
[TBL] [Abstract][Full Text] [Related]
19. Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations.
Badri M; Ehrlich R; Wood R; Maartens G
AIDS; 2001 Jun; 15(9):1143-8. PubMed ID: 11416716
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of malaria preventive treatment for HIV-infected pregnant women in sub-Saharan Africa.
Choi SE; Brandeau ML; Bendavid E
Malar J; 2017 Oct; 16(1):403. PubMed ID: 28985732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
